Idexx Laboratories IDXX
NASDAQ IDXX
$518.00 +4.86 (+0.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Idexx Laboratories (IDXX) Total Non-Current Liabilities (2009 - 2026)

Updated

Idexx Laboratories' Total Non-Current Liabilities was $542.1 million in Q2 2026, down 16.4% from $648.09 million a year earlier but up 2.4% from the prior quarter.

Analysis

Idexx Laboratories (IDXX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Idexx Laboratories came in at $596.56 million, down 5.3% from FY2024.

  • Total Non-Current Liabilities has now declined for five consecutive years, with a five-year compound annual growth rate of -11.2% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $630.21 million in FY2024 (-23.5%), $823.85 million in FY2023 (-8.7%), $902.23 million in FY2022 (-8.3%) and $983.63 million in FY2021 (-8.8%).
  • Quarterly Total Non-Current Liabilities has moved between $529.54 million (Q1 2026) and $996.44 million (Q3 2021) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities has declined for 21 straight quarters, with an average decline of 15.9% over the last eight quarters.
  • Across the past five years, year-over-year decline in Total Non-Current Liabilities ran from 2.2% in Q1 2022 to 24.0% in Q1 2025.
  • Per Business Quant data, IDXX's Total Non-Current Liabilities in the three quarters before Q2 2026 was $529.54 million (Q1 2026), $596.56 million (Q4 2025) and $573.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 105.99 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 106.45 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -967.00 Mn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 81.11 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 36.04 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 100.86 Bn
10 Idexx Laboratories 40.86 Bn 40.07 Bn 779.09 Mn 542.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 542.10 Mn
Mar 31, 2026 529.54 Mn
Dec 31, 2025 596.56 Mn
Sep 30, 2025 573.72 Mn
Jun 30, 2025 648.09 Mn
Mar 31, 2025 629.46 Mn
Dec 31, 2024 630.21 Mn
Sep 30, 2024 723.49 Mn
Jun 30, 2024 717.91 Mn
Mar 31, 2024 827.71 Mn
Dec 31, 2023 823.85 Mn
Sep 30, 2023 818.80 Mn
Jun 30, 2023 893.09 Mn
Mar 31, 2023 901.67 Mn
Dec 31, 2022 902.23 Mn
Sep 30, 2022 974.12 Mn
Jun 30, 2022 983.63 Mn
Mar 31, 2022 981.55 Mn
Dec 31, 2021 983.63 Mn
Sep 30, 2021 996.44 Mn
API Access

Idexx Laboratories Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IDXX&period=max&api_key=YOUR_API_KEY